Records containing: Infectious
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-27Multicentric Observational NAtional Study on LISteriosis and ListeriA
-
CLINICAL_TRIALS study record update · 2025-11-13Does Use of a Facemask Reduce the Risk of Aerosolization During Anesthesia Assisted Upper Endoscopic Procedures: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-07-29Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19
-
CLINICAL_TRIALS study record update · 2016-09-29Evaluation of "UroShield" Device Impact Upon Side Effects and Complications of Urinary Catheter Usage
-
CLINICAL_TRIALS study record update · 2015-03-09A Phase 3, Multicentre, Randomised, Investigator-blinded, Parallel-groupStudy of the Safety and Efficacy of Intravenous Daptomycin (Cubicin®)Compared With That of Comparator (Vancomycin or Vancomycin Followed by Semi-synthetic Penicillin-cloxacillin) in the Treatment of Chinese Subjects With cSSSI
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-08-24A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel (xTAG GPP) in Patients With Signs and Symptoms of Infectious Colitis and Gastroenteritis
-
CLINICAL_TRIALS study record update · 2010-10-19GRACE: An Open-label, Multicenter Trial to Compare the Efficacy, Safety, and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race, When Administered in Combination With an Individually Optimized Background Regimen Over a 48-week Treatment Period.